Ictère grave du nouveau-né par incompatibilité Rhésus. Traitement par immunoglobulines intraveineuses

Archives de Pediatrie

Volumn 6, Issue 3, 1999, Pages 345-

  Sebag, O ^a   Sirvent, N ^b   Dupuy, M ^a   Dageville, C ^b  

^a Centre Hospitalier de Cannes   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; IMMUNOGLOBULIN;

BLOOD; CASE REPORT; HUMAN; LETTER; MALE; NEWBORN; NEWBORN JAUNDICE; RHESUS ISOIMMUNIZATION; TWINS; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; HEMOLYSIS; INFANT; INTRAVENOUS DRUG ADMINISTRATION; NEWBORN HEMOLYTIC DISEASE; PHOTOTHERAPY; TREATMENT INDICATION;

BILIRUBIN; DISEASES IN TWINS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; JAUNDICE, NEONATAL; MALE; RH ISOIMMUNIZATION;

EID: 0032699517     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(99)80288-7     Document Type: Letter

References (2)

1. Labrune P. Ictère grave du nouveau-né. Définition et prise en charge. Arch Pediatr 1998 ; 5 : 1162-7.
2. Hammerman C, Vreman HJ, Kaplan M, Stevenson DK. Intravenous immune globulin in neonatal immune hemolytic disease: does it reduce hemolysis? Acta Paediatr 1996 ; 85 : 1351-3.